Literature DB >> 11302979

The promise and potential hazards of adenovirus gene therapy.

L S Young1, V Mautner.   

Abstract

Mesh：

Year:  2001        PMID： 11302979      PMCID： PMC1728283          DOI： 10.1136/gut.48.5.733

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  57 in total

Review 1.  Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

Authors:  W S Wold; K Doronin; K Toth; M Kuppuswamy; D L Lichtenstein; A E Tollefson
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

Review 2.  Adenovirus vectors for gene delivery.

Authors:  K Benihoud; P Yeh; M Perricaudet
Journal:  Curr Opin Biotechnol       Date:  1999-10       Impact factor: 9.740

3.  Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo.

Authors:  D A Muruve; M J Barnes; I E Stillman; T A Libermann
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 5.695

4.  Circumvention of immunity to the adenovirus major coat protein hexon.

Authors:  S Roy; P S Shirley; A McClelland; M Kaleko
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Authors:  J T Douglas; C R Miller; M Kim; I Dmitriev; G Mikheeva; V Krasnykh; D T Curiel
Journal:  Nat Biotechnol       Date:  1999-05       Impact factor: 54.908

6.  RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection.

Authors:  E Vigne; I Mahfouz; J F Dedieu; A Brie; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae.

Authors:  P W Roelvink; G Mi Lee; D A Einfeld; I Kovesdi; T J Wickham
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

8.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

Authors:  K L Molnar-Kimber; D H Sterman; M Chang; E H Kang; M ElBash; M Lanuti; A Elshami; K Gelfand; J M Wilson; L R Kaiser; S M Albelda
Journal:  Hum Gene Ther       Date:  1998-09-20       Impact factor: 5.695

10.  An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

Authors:  M A Morsy; M Gu; S Motzel; J Zhao; J Lin; Q Su; H Allen; L Franlin; R J Parks; F L Graham; S Kochanek; A J Bett; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205
View more
  8 in total

1.  Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.

Authors:  Ijad Madisch; Soeren Hofmayer; Christian Moritz; Alexander Grintzalis; Jens Hainmueller; Patricia Pring-Akerblom; Albert Heim
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

2.  Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events.

Authors:  Ramsey N Majzoub; Chia-Ling Chan; Kai K Ewert; Bruno F B Silva; Keng S Liang; Cyrus R Safinya
Journal:  Biochim Biophys Acta       Date:  2015-03-06

Review 3.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 4.  Gene therapy in the treatment of intestinal inflammation.

Authors:  Catherine van Montfrans; Anje A te Velde; Sander J H van Deventer; Maria Sol Rodriguez Pena
Journal:  Int J Colorectal Dis       Date:  2003-06-25       Impact factor: 2.571

5.  Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.

Authors:  Ramsey N Majzoub; Chia-Ling Chan; Kai K Ewert; Bruno F B Silva; Keng S Liang; Erica L Jacovetty; Bridget Carragher; Clinton S Potter; Cyrus R Safinya
Journal:  Biomaterials       Date:  2014-03-21       Impact factor: 12.479

Review 6.  Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.

Authors:  David S Strayer; Lokesh Agrawal; Pierre Cordelier; Bianling Liu; Jean-Pierre Louboutin; Elena Marusich; Hayley J McKee; Carmen N NiGongyi Ren; Marlene S Strayer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.860

Review 7.  Adenoviral vectors for gene therapy.

Authors:  Joanne T Douglas
Journal:  Mol Biotechnol       Date:  2007-05       Impact factor: 2.860

8.  Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors.

Authors:  Richard Graveline; Morad Haida; Carolyne Dumont; Dominic Poulin; Florence Poitout-Belissent; Rana Samadfam; Sven Kronenberg; Franziska Regenass-Lechner; Rodney Prell; Marie-Soleil Piche
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.